Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Portage Biotech Inc
PRTG
Healthcare
Biotechnology
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment, response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through...
the translational pipeline. Its adenosine antagonist platform include PORT-9 and PORT-8. PORT-9 and PORT-8 are in the preclinical stage. Its PORT-8 is a dual inhibitor of adenosine receptors 2A and 2B (A2A/A2B) to address solid tumors. Its PORT-9 is an A2B antagonist designed to treat colorectal and gastrointestinal cancers. Its iNKT Engager platform includes PORT- 3, which is in Phase I.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PRTG)
New Post
View:
Posts & Comments
Threaded Posts
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 28, 2025 6:39am
Still holding this stock.
This stock is signalling a continuing uptrend for it this morning,so good luck to all of you
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 28, 2025 8:34am
Buy buddy buy because it's taking off this morning.
It is time for you fellas out there to get on board with this stock already
Largest Integrated Facility Services Provider in Canada Releases Financial Results for Q1, 2025
posted May 11, 2025 9:00am by
GDI Integrated Facility Services Inc.
-
|
Adjusted EBITDA* amounted to $34 million, representing an Adjusted EBITDA* margin of 6% compared to $28 million and 4% in Q1 2024. Net income was $6 million or $0.26 per share compared to $0.4 million or $0.02 per share in Q1 2024.Long-term debt, net of cash* decreased by $14 million in the quarter ...read more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 17, 2024 9:14am
PRTG...early a.m runner up large on NR ($9.15)
P.O set up IMHO....caveat Emptor ; ) EDGAR filing .... https://www.sec.gov/Archives/edgar/data/1095435/000117184324006977/f424b3_121724.htm
(45)
•••
aussyspitz
X
Post by
aussyspitz
on Apr 04, 2022 7:50pm
Criminally undervalued
Long time holder here bought in when this was nothing but a penny stock on the OTC been through some ups and downs but imo this stock is grossly undervalued it was approximately $9 a share following
...more
(0)
•••
Sandy60
X
Post by
Sandy60
on Aug 04, 2021 6:11pm
Sad
Legit stock being played. Baby Biohaven will come back and gift all of us. Sandy
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >